Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2009 Jul 15;200(2):161-3.
doi: 10.1086/599791.

The imperative of influenza vaccines for elderly individuals-an evolving story

Gregory A Poland, Mark J Mulligan
Editorial

The imperative of influenza vaccines for elderly individuals-an evolving story

Gregory A Poland et al. J Infect Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest: G.A.P. serves as an investigator for vaccine clinical studies funded by Wyeth and the National Institutes of Health (NIH). G.A.P. also serves as the chair of a safety evaluation committee for a novel influenza vaccine and other vaccines being developed by Merck Research Laboratories and offers consultative advice on new vaccine development to GlaxoSmithKline, Merck, Novartis, Novavax, Avianix, CSL Limited, and Spaldataq. M.J.M. directs NIH-funded clinical trials of influenza vaccines and adjuvants produced by sanofi pasteur and Novartis. He is an investigator for non-influenza vaccine trials funded by Merck and sanofi pasteur.

Comment on

References

    1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86. - PubMed
    1. Poland GA, Jacobson RM, Ovsyannikova IG. Influenza antiviral resistance: a plea for rational use. Clin Infect Dis. 2009;48:1254–6. - PMC - PubMed
    1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086–96. - PubMed
    1. Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20:1831–6. - PubMed
    1. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661–5. - PubMed

Publication types

MeSH terms